| Chairman |
|
Jing Yue |
| Business Nature |
| 醫療保健 (Health Care) |
| Board Members |
Chairman: Jing Yue General Manager: Yao Xiaodong Executive Director: Li Changqing, Jing Ruihua Non-executive Director: Yu Ailian, Xiao Changqing Independent Non-executive Director: Zou Pingxue, Tsang Hiu Leong, Wu Di.
|
| Principle Business |
|
The Group is principally engaged in the businesses of research and development, and production and sale of human tetanus antitoxin. |
| Major Shareholders |
| Jing Yue | 208,562,250 | H Sh | 67.63% | 67.92% | 2026/06/30 |
|
|
|
|